- Trials with a EudraCT protocol (93)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
93 result(s) found for: Dopaminergic.
Displaying page 1 of 5.
| EudraCT Number: 2004-000394-60 | Sponsor Protocol Number: ACR16C007 | Start Date*: 2004-06-30 |
| Sponsor Name:A. Carlsson Research AB | ||
| Full Title: A randomised phase II multicentre, double blind, parallel group, placebo controlled study of ACR16 50 mg once daily for the symptomatic treatment of Huntington disease | ||
| Medical condition: ACR16 belongs to a new class of CNS active agents called dopaminergic stabilizers. Dopaminergic stabilizers are compounds that can both enhance and counteract dopamine dependent functions in the CN... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) DK (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-003286-34 | Sponsor Protocol Number: CHUBX2017/22 | Start Date*: 2019-03-05 | ||||||||||||||||
| Sponsor Name:CHU de Bordeaux | ||||||||||||||||||
| Full Title: In vivo involvement of the cholinergic and dopaminergic systems in the pathophysiology of apathy. | ||||||||||||||||||
| Medical condition: Apathy | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-000732-26 | Sponsor Protocol Number: ExPD-ESR-18-13512 | Start Date*: 2019-10-23 |
| Sponsor Name:Stockholm Health Care Services | ||
| Full Title: Effect of Exenatide on disease progression in early Parkinson's disease. | ||
| Medical condition: Parkinson's disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001284-12 | Sponsor Protocol Number: PA-01 | Start Date*: 2014-11-19 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: The Role of the Dopamine D2 Receptor System in Pornographic Addiction – A [11C]-Raclopride PET Study | ||
| Medical condition: pornographic addiction | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000155-12 | Sponsor Protocol Number: 2018_49 | Start Date*: 2020-05-12 |
| Sponsor Name:InBrain Pharma SAS | ||
| Full Title: A new concept of continuous dopaminergic stimulation by cerebroventricular administration of A-dopamine (dopamine stored in anaerobia) for severe motor fluctuations in Parkinson’s disease? | ||
| Medical condition: Proof of concept study: prospective, monocentric, controlled randomized study according a cross over design with 2 groups: cerebroventricular administration of A-dopamine versus optimized oral trea... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004583-22 | Sponsor Protocol Number: IDRLS | Start Date*: 2021-06-13 |
| Sponsor Name:Medical University of Innsbruck | ||
| Full Title: Prospective analysis of the therapeutic efficacy of iron isomaltoside in combination with or without dopaminergic therapy in patients with restless legs syndrome | ||
| Medical condition: Restless leg syndorme | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005111-16 | Sponsor Protocol Number: XP-IIT-0029 | Start Date*: 2015-02-16 |
| Sponsor Name:Instituto de Investigaciones del Sueño | ||
| Full Title: Response to gabapentin enacarbil in two groups of RLS patients: Previously exposed to long-term treatment with dopaminergic agents versus dopaminergic treatment-naive patients. | ||
| Medical condition: RLS | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-004825-29 | Sponsor Protocol Number: IIS-2011-01 | Start Date*: 2011-11-30 |
| Sponsor Name:Instituto de Investigaciones del Sueño | ||
| Full Title: TREATMENT WITH ROTIGOTINE OF RLS PATIENTS WITH AN INSUFFICIENT RESPONSE TO DOPAMINE AGONIST WITH INTERMEDIATE HALF-LIFE. | ||
| Medical condition: Restless Legs Syndrom | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000891-54 | Sponsor Protocol Number: REBOOT-II | Start Date*: 2016-11-28 |
| Sponsor Name:Aging Research Center, Karolinska Institutet and Stockholm University | ||
| Full Title: Effects of enhanced dopaminergic neurotransmission on working memory training efficiency in the healthy elderly - A prospective, single center, randomized, double blind, placebo controlled, paralle... | ||
| Medical condition: No medical condition is under investigation. The project investigates normal age-related decline in intellectual abilities. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-006203-36 | Sponsor Protocol Number: NL21082.000.08 | Start Date*: 2007-05-23 | |||||||||||
| Sponsor Name:Academic Medical Centre (AMC) | |||||||||||||
| Full Title: Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndrome | |||||||||||||
| Medical condition: Dementia in velocardiofacial syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-006151-20 | Sponsor Protocol Number: D1449L00029 | Start Date*: 2006-08-29 | |||||||||||
| Sponsor Name:University of Erlangen-Nuremberg | |||||||||||||
| Full Title: Quetiapine and the dopaminergic epigenetic control – a pilot study | |||||||||||||
| Medical condition: Patients suffering from schizophrenia (ICD10: F20.x) Healthy controls | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-002578-36 | Sponsor Protocol Number: 2008/0817 | Start Date*: 2008-09-10 |
| Sponsor Name:CHRU de LILLE | ||
| Full Title: Etude d’efficacité et d’acceptabilité d’un traitement cholinergique dans l’apathie parkinsonienne “Cholinergic treatment in Parkinsonian Apathy: ChoPA - I” | ||
| Medical condition: Parkinsonian Apathy without dementia and depression in spite of dopaminergic treatment | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-002342-11 | Sponsor Protocol Number: D1449L00033 | Start Date*: 2007-04-19 |
| Sponsor Name:Klinikum Fulda gAG | ||
| Full Title: Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffer... | ||
| Medical condition: Patients have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001315-71 | Sponsor Protocol Number: DPSANARI2012 | Start Date*: 2013-10-17 | |||||||||||
| Sponsor Name:Mercedes Zumarraga Ortiz | |||||||||||||
| Full Title: Dopaminergic genotype of schizophrenic patients and the benefit of adjunctive aripiprazole to risperidone treatment. The effect on hormonal and metabolic measures | |||||||||||||
| Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-004129-89 | Sponsor Protocol Number: Motor-Neuromod_01, Part I-III | Start Date*: 2005-09-19 |
| Sponsor Name:Universitätsklinikum Münster | ||
| Full Title: Potentiation of procedural motor learning by pharmacological neuromodulation and brain stimulation | ||
| Medical condition: Healthy volunteers Patients in the chronic stage (> 1 year) after stroke | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-003254-17 | Sponsor Protocol Number: IIBSP-SAF-2017-75 | Start Date*: 2017-12-21 |
| Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau | ||
| Full Title: A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Safinamide on Apathy in Patients With Parkinson's Disease | ||
| Medical condition: Parkinson's disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-006302-28 | Sponsor Protocol Number: OXYGENE | Start Date*: 2012-07-11 |
| Sponsor Name:UNIVERSITA' DEGLI STUDI DI PARMA | ||
| Full Title: Dopamine modulation of oxytocin prosocial effects | ||
| Medical condition: HEALTHY VOLUNTEERS. FOR PATIENTS WITH AUTISM OR SCHIZOPHRENIA | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: IT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005567-26 | Sponsor Protocol Number: TVN67 | Start Date*: 2007-09-03 |
| Sponsor Name:University of Aachen | ||
| Full Title: Effects of deep brain stimulation of the nucleus accumbens on the dopaminergic activity in patients with Gilles-de-la-Tourette-syndrome | ||
| Medical condition: The participants under study are recruited from a sample of patients suffering from a severe form of the Gilles-de-la-Tourette-syndrome who are waiting to receive deep-brain stimulation of the ncl.... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-001650-29 | Sponsor Protocol Number: MF02/11 | Start Date*: 2011-12-19 |
| Sponsor Name:A. Carlsson Research AB | ||
| Full Title: TREATMENT OF MENTAL FATIGUE ("BRAIN FATIGUE") WITH THE DOPAMINERGIC STABILIZER OSU6162 AFTER STROKE AND MILD/MODERATE TRAUMATIC BRAIN INJURY– INCREASE OF PATIENT NUMBER | ||
| Medical condition: Mental fatigue after stroke or mild to moderate head trauma | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-000434-21 | Sponsor Protocol Number: LP1 | Start Date*: 2005-06-15 |
| Sponsor Name:Kognitive Neurologie, Institut für Medizin, Forschungszentrum Jülich | ||
| Full Title: Neurochemische Modulation von Exekutiv- und Gedächtnisfunktionen | ||
| Medical condition: Progressive cognitive decline in physiological aging | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
